STK11 and neoplasm: Based on a previously published work [72], the Authors speculated that the concomitant loss of STK11 together with mutations in an oncogenic pathway (KRAS/RAF) promotes IL-6 secretion by tumor cells, which, in turn, can determine the recruitment of neutrophils in the tumor microenvironment.